4
Changes in Ownership
AIM ImmunoTech Inc. Filed Acc 0001450324-19-000008
Exec. Vice Chairman/CEO/Pres. acquired 325,065 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
EQUELS THOMAS K. · Exec. Vice Chairman/CEO/Pres.
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2019-02-27 | Option exercise : show line 1 in the form | +65 | 65 | D |
| 2019-02-27 | Option exercise : show line 2 in the form | +325,000 | 325,000 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2019-02-27 | Option exercise : show line 3 in the form Subr Rights(to buy) | +65 | $1,000.00 | $65,000 | 0 | D |
Loading xslF345X03/primary_doc.xml…